Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
rivaroxaban, Quantity: 20 mg
Dr Reddys Laboratories Australia Pty Ltd
Tablet, film coated
Excipient Ingredients: hypromellose; iron oxide red; titanium dioxide; croscarmellose sodium; sodium lauryl sulfate; microcrystalline cellulose; lactose monohydrate; purified talc; macrogol 4000
Oral
7, 84, 100, 28, 98
(S4) Prescription Only Medicine
Rivaroxaban is indicated for:,? Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for the prevention of recurrent DVT and PE.
Visual Identification: Dark red coloured, round biconvex film-coated tablets, engraved with '20' on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2023-01-04